- Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinomaLi Wenhua; Liu Ling; Liu Di; Jin Shimao; Yang Yisha; Tang Wei; Gong LeiBiochemical and Biophysical Research Communications, 2016, 472(1): 156-162.
- The MiR-135b-BMAL1-YY1 loop disturbs pancreatic clockwork to promote tumourigenesis and chemoresistanceJiang Weiliang; Zhao Senlin; Shen Jia; Guo Lihong; Sun Yi; Zhu Yuntian; Ma Zhixiong; Zhang Xin; Hu Yangyang; Xiao Wenqin; Li Kai; Li Sisi; Zhou Li; Huang Li; Lu Zhanjun; Feng Yun; Xiao Junhua; Zhang Eric Erquan; Yang Lijuan; Wan RongCELL DEATH & DISEASE, 2018, 9: 149.
- Circadian Clock Gene Bmal1 Inhibits Tumorigenesis and Increases Paclitaxel Sensitivity in Tongue Squamous Cell CarcinomaTang Qingming; Cheng Bo; Xie Mengru; Chen Yatao; Zhao Jiajia; Zhou Xin; Chen LiliCancer Research, 2017, 77(2): 532-544.
期刊论文
The circadian clock gene Bmal1 acts as a potential anti-oncogene in pancreatic cancer by activating the p53 tumor suppressor pathway
11阅读
